Previous Close | 298.90 |
Open | 310.10 |
Bid | 309.90 x 10000 |
Ask | 312.90 x 10000 |
Day's Range | 310.10 - 310.10 |
52 Week Range | 280.70 - 494.10 |
Volume | |
Avg. Volume | 8 |
Market Cap | 37.513B |
Beta (5Y Monthly) | 0.50 |
PE Ratio (TTM) | 20.58 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 3.33 (1.07%) |
Ex-Dividend Date | Jun 28, 2024 |
1y Target Est | N/A |
Believes Enhabit’s Shares Do Not Reflect its Intrinsic Value or Strategic Potential Has Nominated Seven Highly Qualified Independent Directors Believes AREX Slate Would Provide Board With Sorely Needed Home Health and Hospice Expertise NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the be
LOUISVILLE, Ky., May 02, 2024--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at B of A Securities Health Care Conference on Tuesday, May 14, 2024, at 8:00 a.m. Pacific time.
BATON ROUGE, La., April 25, 2024--Humana Healthy Horizons commits $500,000 to improve the health of Louisianians.